graft vs host disease

نتایج جستجو برای: graft vs host disease

تعداد نتایج: 1890551 فیلتر نتایج به سال:

non-myeloablative stem cell transplantation in hematologic malig¬nancies: an experience from the hematology-oncology and bmt re¬search center

Journal: :international journal of hematology-oncology and stem cell research 0

s keyhanian oncologist-hematologist, azad eslami university of medicine, tonekabon a ghavamzadeh oncologist-hematologist, hematology- oncology and bmt research center tehran university of medical sciences b bahar oncologist-hematologist, hematology- oncology and bmt research center tehran university of medical sciences k alimoghaddam oncologist-hematologist, hematology- oncology and bmt research center tehran university of medical sciences ar shamshiri student of epidemiology, hematology- oncology and bmt research center tehran university of medical sciences s gholibeikian data manager, hematology- oncology and bmt research center tehran university of medical sciences

background: myeloablative-allogeneic stem cell transplantation is a common way of treating various malignant and nonma-lignant diseases; but, it is associated with hazardous immediate and late complications. the majority of patients are not good candidates for high dose therapy because of old age, medical co-morbidities or previous heavy treatments. the donor stem cells can engraft in the recip...